302440 logo

SK Bioscience Co Ltd (302440)

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus v...

KOHealthcareBiotechnologyKorea

Company Profile

Stock Code
302440
ISIN Code
KR7302440003
Currency
Korean Won (KRW)

Contact Information

Company Address
310, Pangyo-ro, Seongnam-si, South Korea, 13494
Contact Phone
82 2 2008 2200
Company Website
https://www.skbioscience.co.kr
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-3.24%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99